| scholarly article | Q13442814 |
| P2093 | author name string | María F Troncoso | |
| María L Bacigalupo | |||
| Pablo Carabias | |||
| P2860 | cites work | Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma | Q39508641 |
| A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer | Q24336874 | ||
| Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors | Q24337334 | ||
| microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity | Q24620203 | ||
| Current and emerging therapies in unresectable and recurrent gastric cancer | Q26745453 | ||
| Gastric cancer: The times they are a-changin' | Q26776195 | ||
| Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge | Q26777538 | ||
| Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value | Q26827351 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Management of HCC | Q28258769 | ||
| Oncogenic mechanisms of the Helicobacter pylori CagA protein | Q28280246 | ||
| Galectins: structure, function and therapeutic potential | Q28283659 | ||
| Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma | Q28550036 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification | Q29618627 | ||
| Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation | Q30620697 | ||
| Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. | Q31034362 | ||
| Preliminary proteomic analysis of indomethacin's effect on tumor transplanted with colorectal cancer cell in nude mice | Q33238524 | ||
| Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials | Q33299698 | ||
| Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma | Q33325583 | ||
| Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness | Q33692511 | ||
| Colorectal cancer: from prevention to personalized medicine. | Q33735234 | ||
| Fibrosis-dependent mechanisms of hepatocarcinogenesis | Q33865082 | ||
| Suppression of tumor growth and metastasis in Mgat5-deficient mice | Q33892088 | ||
| Colon cancer screening | Q34029800 | ||
| Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. | Q39578275 | ||
| Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells | Q39625206 | ||
| Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells | Q39696500 | ||
| Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. | Q39890623 | ||
| Varied expression and localization of multiple galectins in different cancer cell lines | Q40010878 | ||
| N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration | Q40238492 | ||
| Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells | Q40591181 | ||
| Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements | Q40617232 | ||
| Delineating the "galectin signature" of the tumor microenvironment | Q40725115 | ||
| Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures | Q40797947 | ||
| Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate | Q41429036 | ||
| Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma | Q41684858 | ||
| Liver transplantation for hepatocellular carcinoma on cirrhosis: Strategies to avoid tumor recurrence | Q43000512 | ||
| Tumor cells secrete galectin-1 to enhance endothelial cell activity. | Q44132717 | ||
| Myenteric denervation reduces the incidence of gastric tumors in rats | Q44283722 | ||
| Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways | Q44368608 | ||
| Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence | Q44391422 | ||
| Global burden of gastric cancer attributable to Helicobacter pylori | Q44946941 | ||
| High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients | Q44957730 | ||
| Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells | Q45153727 | ||
| Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis | Q45885229 | ||
| Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. | Q46296450 | ||
| The implication of N-acetylglucosaminyltransferase V expression in gastric cancer | Q46309400 | ||
| Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. | Q46654963 | ||
| Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells | Q46864651 | ||
| Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting | Q47995916 | ||
| Myenteric denervation downregulates galectin-1 and -3 expression in gastric carcinogenesis. | Q50439270 | ||
| Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles | Q51586934 | ||
| Modulation of galactoside-binding lectins in tumor cells by differentiation-inducing agents | Q52244211 | ||
| The expression profiles of the galectin gene family in colorectal adenocarcinomas | Q53086499 | ||
| Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway | Q53143098 | ||
| Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells | Q53284113 | ||
| An application of the 2‐nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery | Q53474321 | ||
| Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer | Q53600526 | ||
| Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry | Q53629351 | ||
| Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model | Q54486460 | ||
| Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. | Q54657364 | ||
| Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer | Q55055061 | ||
| Clinical significance of circulating galectins as colorectal cancer markers | Q56601187 | ||
| Colorectal cancer | Q57191694 | ||
| Quantitative Proteomic and Genomic Profiling Reveals Metastasis-Related Protein Expression Patterns in Gastric Cancer Cells | Q63641884 | ||
| N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis | Q72608113 | ||
| Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer | Q73644483 | ||
| Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis | Q73803378 | ||
| Differential expression of galectin 3 and galectin 1 in colorectal cancer progression | Q73933595 | ||
| Proteome analysis of rat hepatic stellate cells | Q74071343 | ||
| Galectin-1 and galectin-3 in chronic pancreatitis | Q74194859 | ||
| Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma | Q74303893 | ||
| Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma | Q77670153 | ||
| Acinar‐to‐ductal metaplasia accompanies c‐myc‐induced exocrine pancreatic cancer progression in transgenic rodents | Q82181907 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance | Q83005419 | ||
| Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection | Q83701996 | ||
| Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis | Q84100587 | ||
| High expression of Galectin‐1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer | Q84584414 | ||
| Pancreatic cancer | Q87198210 | ||
| Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo | Q34382230 | ||
| Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling | Q34467671 | ||
| Gastric cancer: Classification, histology and application of molecular pathology | Q34642023 | ||
| Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma | Q34797866 | ||
| Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. | Q34837887 | ||
| Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays | Q34928555 | ||
| Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell | Q34970766 | ||
| Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma | Q35111396 | ||
| Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy | Q35127584 | ||
| Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resist | Q35692109 | ||
| Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1. | Q35713332 | ||
| Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis | Q35834086 | ||
| The Global Burden of Cancer 2013 | Q35847426 | ||
| Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway | Q35974260 | ||
| Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer | Q36095578 | ||
| Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma | Q36149299 | ||
| Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma | Q36340825 | ||
| Suppression of anti-cancer immunity by regulatory T cells: back to the future | Q36352541 | ||
| A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells | Q36424099 | ||
| Galectin-1: a small protein with major functions | Q36535706 | ||
| Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer | Q36616418 | ||
| Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma | Q36625697 | ||
| Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival | Q36819503 | ||
| Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer | Q36879539 | ||
| MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism | Q37033307 | ||
| N-Glycans in cancer progression | Q37243167 | ||
| Pancreatic tumor pathogenesis reflects the causative genetic lesion | Q37359551 | ||
| Galectin-1 is essential for efficient liver regeneration following hepatectomy | Q37362507 | ||
| Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer | Q37410368 | ||
| Quantitative proteomics investigation of pancreatic intraepithelial neoplasia | Q37416043 | ||
| Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up | Q37489147 | ||
| Expression of galectin-1 in malignant tumors. | Q37529237 | ||
| Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled | Q37578725 | ||
| Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression | Q37583130 | ||
| MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma | Q37636762 | ||
| Deregulation of annexin-A1 and galectin-1 expression in precancerous gastric lesions: intestinal metaplasia and gastric ulcer | Q37639722 | ||
| Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway | Q37696353 | ||
| Diagnostic accuracy of computed tomography for colon cancer staging: A systematic review | Q37866809 | ||
| The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease | Q37899185 | ||
| Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics | Q37970602 | ||
| Medical therapies for hepatocellular carcinoma: a critical view of the evidence | Q38059437 | ||
| Unraveling galectin-1 as a novel therapeutic target for cancer | Q38129509 | ||
| Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma | Q38174863 | ||
| Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells | Q38301301 | ||
| Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells | Q38320455 | ||
| Galectin-1 is an inductor of pancreatic stellate cell activation | Q38323328 | ||
| Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression | Q38334678 | ||
| Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages | Q38337272 | ||
| Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin. | Q38339024 | ||
| Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue | Q38354491 | ||
| Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. | Q38358877 | ||
| Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration | Q38359998 | ||
| Galectin expression in cancer diagnosis and prognosis: A systematic review. | Q38394821 | ||
| Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet | Q38726096 | ||
| Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering | Q38777463 | ||
| Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways | Q38796373 | ||
| Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression | Q38839374 | ||
| Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer | Q38851181 | ||
| Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells | Q38932655 | ||
| E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. | Q39152300 | ||
| Galectin-1 and Galectin-3 Mediate Protocadherin-24-Dependent Membrane Localization of β-catenin in Colon Cancer Cell Line HCT116 | Q39250900 | ||
| Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach | Q39351950 | ||
| Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium | Q39470886 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | signal transduction | Q828130 |
| neovascularization | Q1281049 | ||
| Galectin 1 | Q5518317 | ||
| gastrointestinal neoplasm | Q58833942 | ||
| neoplastic gene expression regulation | Q66660300 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 5266-5281 | |
| P577 | publication date | 2017-08-01 | |
| 2017-08-07 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression | |
| P478 | volume | 23 |
Search more.